CardioPrecision, a Scottish company specializing in less invasive treatment of structural heart disease, achieves a “global breakthrough” by demonstrating a proof-of-concept Advanced Videoscopic Aortic valve surgery by Transcervical Approach using Robot-assistance (AVATAR) procedure in Chicago, Illinois, USA. The successful procedure, performed on human cadavers, marks a significant milestone in advancing towards clinical cases and showcases the potential for less invasive heart surgeries using robotic assistance, with support from leading cardiothoracic surgeons in both Scotland and the USA.
Abbott receives CE mark for its Assert-IQ insertable cardiac monitor with a six-year battery life, offering longer-term monitoring of patients at risk of developing arrhythmias compared to rival devices with shorter lifespans. The device, the size of a paper clip, continuously monitors heart rhythms and is designed for both traditional monitoring applications and monitoring patients undergoing therapy, providing clinicians with more clinically relevant information for faster and more precise clinical decisions.
SyntheticMR’s next-generation 3D brain imaging solution, SyMRI 3D, receives FDA 510(k) clearance, marking a significant advancement in quantitative MRI technology. This isotropic resolution platform enables precise volumetric estimations of brain regions, offering unprecedented resolution and accuracy in brain imaging, and empowering physicians to make more informed decisions in diagnosis and treatment planning.
Serum Detect, a cancer diagnostics company, introduces a novel approach for early cancer detection at the AACR conference, focusing on T-cell analysis. Leveraging liquid biopsy samples and advanced computational techniques, the company aims to develop diagnostic tests that enhance existing screening methods, potentially improving detection capabilities for early-stage cancer.
RefleXion Medical has partnered with Limbus AI to integrate Limbus Contour software into its radiotherapy treatment planning system, aiming to streamline cancer treatment planning with automated contouring. This collaboration is expected to reduce contouring time by up to 80%, ensuring patients receive timely and precise radiation therapy. Additionally, the incorporation of Limbus Contour is anticipated to benefit both biologic and anatomic treatment modalities on RefleXion’s X1 radiotherapy platform.
ThinkMedTek 
Leave a comment